Literature DB >> 11918869

TGF-beta-mediated control of allergen-specific T-cell responses.

Carsten B Schmidt-Weber1, Steffen Kunzmann, Kurt Blaser.   

Abstract

Control of allergen-specific response by suppressive cytokines involves several layers of regulation, including secretion of the cytokine, deviation of cytokine expression by altered T-cell differentiation, immediate (de-) phosphorylation events upon binding of suppressive cytokines, and laterations in susceptibility of suppression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11918869     DOI: 10.1007/s11882-002-0028-8

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  58 in total

Review 1.  Smad transcriptional corepressors in TGF beta family signaling.

Authors:  D Wotton; J Massagué
Journal:  Curr Top Microbiol Immunol       Date:  2001       Impact factor: 4.291

Review 2.  IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy.

Authors:  C A Akdis; K Blaser
Journal:  FASEB J       Date:  1999-04       Impact factor: 5.191

3.  IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway.

Authors:  A Joss; M Akdis; A Faith; K Blaser; C A Akdis
Journal:  Eur J Immunol       Date:  2000-06       Impact factor: 5.532

Review 4.  TGF-beta influences the life and death decisions of T lymphocytes.

Authors:  S M Wahl; J M Orenstein; W Chen
Journal:  Cytokine Growth Factor Rev       Date:  2000 Mar-Jun       Impact factor: 7.638

5.  TGF-beta promotes immune deviation by altering accessory signals of antigen-presenting cells.

Authors:  M Takeuchi; P Alard; J W Streilein
Journal:  J Immunol       Date:  1998-02-15       Impact factor: 5.422

6.  Induction and differential regulation of bee venom phospholipase A2-specific human IgE and IgG4 antibodies in vitro requires allergen-specific and nonspecific activation of T and B cells.

Authors:  C A Akdis; T Blesken; M Akdis; S S Alkan; B Wüthrich; C H Heusser; K Blaser
Journal:  J Allergy Clin Immunol       Date:  1997-03       Impact factor: 10.793

7.  Fas- and activation-induced apoptosis are reduced in human T cells preactivated in the presence of TGF-beta 1.

Authors:  A Cerwenka; H Kovar; O Majdic; W Holter
Journal:  J Immunol       Date:  1996-01-15       Impact factor: 5.422

8.  TGF-beta1 down-regulates Th2 development and results in decreased IL-4-induced STAT6 activation and GATA-3 expression.

Authors:  V L Heath; E E Murphy; C Crain; M G Tomlinson; A O'Garra
Journal:  Eur J Immunol       Date:  2000-09       Impact factor: 5.532

9.  Transforming growth factor-beta (TGF-beta)-resistant helper T lymphocyte clones show a concomitant loss of all three types of TGF-beta receptors.

Authors:  C Siepl; U V Malipiero; A Fontana
Journal:  J Immunol       Date:  1991-05-01       Impact factor: 5.422

10.  Decreased release of histamine and sulfidoleukotrienes by human peripheral blood leukocytes after wasp venom immunotherapy is partially due to induction of IL-10 and IFN-gamma production of T cells.

Authors:  M Pierkes; I Bellinghausen; T Hultsch; G Metz; J Knop; J Saloga
Journal:  J Allergy Clin Immunol       Date:  1999-02       Impact factor: 10.793

View more
  4 in total

Review 1.  Interleukin-10-secreting regulatory T cells in allergy and asthma.

Authors:  Zoë Urry; Emmanuel Xystrakis; Catherine M Hawrylowicz
Journal:  Curr Allergy Asthma Rep       Date:  2006-09       Impact factor: 4.806

Review 2.  Immunological mechanisms in specific immunotherapy.

Authors:  Carsten B Schmidt-Weber; Kurt Blaser
Journal:  Springer Semin Immunopathol       Date:  2003-10-24

3.  Neuroimmune semaphorin 4D is necessary for optimal lung allergic inflammation.

Authors:  K Shanks; E H Nkyimbeng-Takwi; E Smith; M M Lipsky; L J DeTolla; D W Scott; A D Keegan; S P Chapoval
Journal:  Mol Immunol       Date:  2013-08-01       Impact factor: 4.407

4.  IFN-γ and TNF-α synergize to inhibit CTGF expression in human lung endothelial cells.

Authors:  Roderich Laug; Markus Fehrholz; Norbert Schütze; Boris W Kramer; Vera Krump-Konvalinkova; Christian P Speer; Steffen Kunzmann
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.